191 related articles for article (PubMed ID: 36792985)
1. Reduced numbers of regulatory T cells in chronic heart failure seems not to be restored by cardiac resynchronization therapy.
Martins S; António N; Carvalheiro T; Laranjeira P; Rodrigues R; Gonçalves L; Tomaz C; Paiva A
BMC Cardiovasc Disord; 2023 Feb; 23(1):89. PubMed ID: 36792985
[TBL] [Abstract][Full Text] [Related]
2. Impact of cardiac resynchronization therapy on circulating IL-17 producing cells in patients with advanced heart failure.
Martins S; Carvalheiro T; Laranjeira P; Martinho A; Elvas L; Gonçalves L; Tomaz C; António N; Paiva A
J Interv Card Electrophysiol; 2019 Apr; 54(3):257-265. PubMed ID: 30483979
[TBL] [Abstract][Full Text] [Related]
3. Role of monocytes and dendritic cells in cardiac reverse remodelling after cardiac resynchronization therapy.
Martins S; António N; Rodrigues R; Carvalheiro T; Tomaz C; Gonçalves L; Paiva A
BMC Cardiovasc Disord; 2023 Nov; 23(1):558. PubMed ID: 37968611
[TBL] [Abstract][Full Text] [Related]
4. The cost of non-response to cardiac resynchronization therapy: characterizing heart failure events following cardiac resynchronization therapy.
Varma N; Auricchio A; Connolly AT; Boehmer J; Bahu M; Costanzo MR; Leonelli F; Yoo D; Singh J; Nabutovsky Y; Gold M
Europace; 2021 Oct; 23(10):1586-1595. PubMed ID: 34198334
[TBL] [Abstract][Full Text] [Related]
5. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.
Arrigo M; Truong QA; Szymonifka J; Rivas-Lasarte M; Tolppanen H; Sadoune M; Gayat E; Cohen-Solal A; Ruschitzka F; Januzzi JL; Singh JP; Mebazaa A
Europace; 2017 Nov; 19(11):1848-1854. PubMed ID: 28096288
[TBL] [Abstract][Full Text] [Related]
6. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
[TBL] [Abstract][Full Text] [Related]
7. An exploratory study on coronary sinus lead tip three-dimensional trajectory changes in cardiac resynchronization therapy.
Tomasi C; Corsi C; Turco D; Severi S
Heart Rhythm; 2013 Sep; 10(9):1360-7. PubMed ID: 23851066
[TBL] [Abstract][Full Text] [Related]
8. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
[TBL] [Abstract][Full Text] [Related]
10. Intrathoracic impedance changes reflect reverse left ventricular remodeling in response to cardiac resynchronization therapy in chronic heart failure patients.
Kaneshiro T; Suzuki H; Yamada S; Kamiyama Y; Saitoh S; Takeishi Y
Int Heart J; 2012; 53(4):249-52. PubMed ID: 22878804
[TBL] [Abstract][Full Text] [Related]
11. Interaction of Left Ventricular Size and Sex on Outcome of Cardiac Resynchronization Therapy Among Patients With a Narrow QRS Duration in the EchoCRT Trial.
Varma N; Sogaard P; Bax JJ; Abraham WT; Borer JS; Dickstein K; Singh JP; Gras D; Holzmeister J; Brugada J; Ruschitzka F
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29807890
[TBL] [Abstract][Full Text] [Related]
12. Cardiac resynchronization therapy reduces expression of inflammation-promoting genes related to interleukin-1β in heart failure.
Bilchick K; Kothari H; Narayan A; Garmey J; Omar A; Capaldo B; McNamara C
Cardiovasc Res; 2020 Jun; 116(7):1311-1322. PubMed ID: 31612215
[TBL] [Abstract][Full Text] [Related]
13. Melatonin is associated with reverse remodeling after cardiac resynchronization therapy in patients with heart failure and ventricular dyssynchrony.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Piccolo R; Galasso G; Reiter RJ
Int J Cardiol; 2016 Oct; 221():359-63. PubMed ID: 27404706
[TBL] [Abstract][Full Text] [Related]
14. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
15. Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy.
Schmidt S; Hürlimann D; Starck CT; Hindricks G; Lüscher TF; Ruschitzka F; Steffel J
Eur Heart J; 2014 Apr; 35(16):1051-60. PubMed ID: 24371079
[TBL] [Abstract][Full Text] [Related]
16. Effect of Diabetes Mellitus on Cardiac Resynchronization Therapy and to Prognosis in Heart Failure (from the Prospective Evaluation of Asian With Cardiac Resynchronization Therapy for Heart Failure Study).
Tan ESJ; Lim J; Chan SP; Seow JT; Singh D; Yeo WT; Lim TW; Kojodjojo P; Seow SC
Am J Cardiol; 2019 Sep; 124(6):899-906. PubMed ID: 31326077
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter Mitral Valve Repair in Patients With and Without Cardiac Resynchronization Therapy: The COAPT Trial.
Kosmidou I; Lindenfeld J; Abraham WT; Kar S; Lim DS; Mishell JM; Whisenant BK; Kipperman RM; Boudoulas KD; Redfors B; Shahim B; Zhang Z; Mack MJ; Stone GW
Circ Heart Fail; 2020 Nov; 13(11):e007293. PubMed ID: 33176460
[TBL] [Abstract][Full Text] [Related]
18. Effect of Cardiac Resynchronization Therapy on Exercise-Induced Pulmonary Hypertension and Right Ventricular-Arterial Coupling.
Martens P; Verbrugge FH; Bertrand PB; Verhaert D; Vandervoort P; Dupont M; Tang WHW; Janssens S; Mullens W
Circ Cardiovasc Imaging; 2018 Sep; 11(9):e007813. PubMed ID: 30354673
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-α predicts response to cardiac resynchronization therapy in patients with chronic heart failure.
Rordorf R; Savastano S; Sanzo A; Spazzolini C; De Amici M; Camporotondo R; Ghio S; Vicentini A; Petracci B; De Regibus V; Taravelli E; Landolina M; Schwartz PJ
Circ J; 2014; 78(9):2232-9. PubMed ID: 24954238
[TBL] [Abstract][Full Text] [Related]
20. Gender-related safety and efficacy of cardiac resynchronization therapy.
Schuchert A; Muto C; Maounis T; Frank R; Ella RO; Polauck A; Padeletti L;
Clin Cardiol; 2013 Nov; 36(11):683-90. PubMed ID: 24105909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
